About the Authors

Jarir At Thobari

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Writing – original draft

j.atthobari@ugm.ac.id

Affiliations Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia, Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia, Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia

Cahya Dewi Satria

Roles Conceptualization, Investigation, Methodology, Project administration

Affiliations Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia, Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia

Yohanes Ridora

Roles Formal analysis, Writing – original draft

Affiliation Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia

Emma Watts

Roles Data curation, Formal analysis, Methodology, Project administration, Validation, Writing – original draft

Affiliation RV3 Rotavirus Vaccine Program, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

Amanda Handley

Roles Data curation, Methodology, Project administration

Affiliations RV3 Rotavirus Vaccine Program, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Medicines Development for Global Health, Melbourne, Victoria, Australia

Jane Standish

Roles Data curation, Formal analysis, Methodology, Project administration, Validation

Affiliations RV3 Rotavirus Vaccine Program, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Department of General Medicine, Royal Children’s Hospital Melbourne, Parkville, Victoria, Australia

Novilia S. Bachtiar

Roles Conceptualization, Methodology, Resources, Writing – review & editing

Affiliation PT Bio Farma, Bandung, West Java, Indonesia

Jim P. Buttery

Roles Conceptualization, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing

Affiliations RV3 Rotavirus Vaccine Program, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia, Department of Paediatrics, Monash University, Clayton, Victoria, Australia, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia, Department of Infection and Immunity, Monash Children’s Hospital, Clayton, Victoria, Australia

Yati Soenarto

Roles Conceptualization, Methodology, Supervision, Writing – review & editing

Affiliations Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia, Department of Paediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia

Julie E. Bines

Roles Conceptualization, Methodology, Resources, Supervision, Validation, Writing – review & editing

Affiliations RV3 Rotavirus Vaccine Program, Murdoch Children’s Research Institute, Parkville, Victoria, Australia, Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia, Department of Gastroenterology and Clinical Nutrition, Royal Children’s Hospital Melbourne, Parkville, Victoria, Australia

Competing Interests

The authors have the following interests: NSB is a paid employee of PT Biofarma. PT Biofarma is a state-owned company (owned by Indonesia government) that provides all vaccines for Indonesia National Immunization Program. Additionally, PT Biofarma was one of the non-commercial funders for the RV3-BB Phase IIB trial. No consultation was done to the funder relating to the trial. The trial was a phase IIB trial and while the RV3-BB rotavirus vaccine is not yet marketed, this vaccine is being developed with the intention for eventual usage in the national immunization program. This does not alter our adherence to PLOS ONE policies on sharing data and materials.